BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:29 PM
 | 
Aug 27, 2012
 |  BC Extra  |  Company News

FDA places hold on second Idenix HCV compound

Idenix Pharmaceuticals Inc. (NASDAQ:IDIX) said FDA placed a clinical hold on IDX19368, a nucleotide HCV NS5B polymerase inhibitor that was slated to start human testing this quarter. According to Idenix, the agency placed the hold as a precautionary measure following cardiac...

Read the full 199 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >